Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D de Zeeuw

Showing results (61-70 of 223) with videos related to

Pageof 23
Sort By:
Annals of Internal Medicine|March 15, 1989
Unilateral renal parenchymal disease with contralateral renal artery stenosis of the fibrodysplasia typeP E de Jong, J H van Bockel, D de Zeeuw
American Journal of Nephrology|January 1, 1990
Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinoprilJ E Heeg, P E de Jong, R Vriesendorp, et al.
Hypertension (Dallas, Tex. : 1979)|February 1, 1996
Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?P van Paassen, D de Zeeuw, G Navis, et al.
Pharmaceutisch Weekblad. Scientific Edition|August 21, 1992
Clearance of indomethacin occurs predominantly by renal glucuronidationF Moolenaar, S Crancrinus, J Visser, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 7, 2002
Intracellular angiotensin II: from myth to reality?C M Filipeanu, R H Henning, S A Nelemans, et al.
Drug Safety|September 1, 1996
ACE inhibitors and the kidney. A risk-benefit assessmentG Navis, H J Faber, D de Zeeuw, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2000
Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal functionP van Paassen, D de Zeeuw, G Navis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1995
Proteinuria: a risk factor for pregnancy-related renal function decline in primary glomerular disease?M H Hemmelder, D de Zeeuw, V Fidler, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 19, 1991
[Angiotensin-converting enzyme inhibitors in the treatment of proteinuria]P E de Jong, D de Zeeuw, G K van der Hem
Experimental Nephrology|January 1, 1996
Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal diseaseF H Wapstra, G Navis, P E de Jong, et al.
Pageof 23

Showing results (61-70 of 223) with videos related to

Sort By:
Pageof 23
Annals of Internal Medicine|March 15, 1989
Unilateral renal parenchymal disease with contralateral renal artery stenosis of the fibrodysplasia typeP E de Jong, J H van Bockel, D de Zeeuw
American Journal of Nephrology|January 1, 1990
Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinoprilJ E Heeg, P E de Jong, R Vriesendorp, et al.
Hypertension (Dallas, Tex. : 1979)|February 1, 1996
Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?P van Paassen, D de Zeeuw, G Navis, et al.
Pharmaceutisch Weekblad. Scientific Edition|August 21, 1992
Clearance of indomethacin occurs predominantly by renal glucuronidationF Moolenaar, S Crancrinus, J Visser, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|March 7, 2002
Intracellular angiotensin II: from myth to reality?C M Filipeanu, R H Henning, S A Nelemans, et al.
Drug Safety|September 1, 1996
ACE inhibitors and the kidney. A risk-benefit assessmentG Navis, H J Faber, D de Zeeuw, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2000
Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal functionP van Paassen, D de Zeeuw, G Navis, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1995
Proteinuria: a risk factor for pregnancy-related renal function decline in primary glomerular disease?M H Hemmelder, D de Zeeuw, V Fidler, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 19, 1991
[Angiotensin-converting enzyme inhibitors in the treatment of proteinuria]P E de Jong, D de Zeeuw, G K van der Hem
Experimental Nephrology|January 1, 1996
Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal diseaseF H Wapstra, G Navis, P E de Jong, et al.
Pageof 23